Screener
Bristol-Myers Squibb BMY Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's operating lease liabilities (current)?
- Bristol-Myers Squibb (BMY) reported operating lease liabilities (current) of $207M in Q2 2026.
- How has Bristol-Myers Squibb's operating lease liabilities (current) changed year-over-year?
- Bristol-Myers Squibb's operating lease liabilities (current) increased by 6.7% year-over-year, from $194M to $207M.
- What is the long-term trend for Bristol-Myers Squibb's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's operating lease liabilities (current) has grown at a 4.3% compound annual growth rate (CAGR), from $164M to $202M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Bristol-Myers Squibb's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude